Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Case Reports in Vascular Medicine
|
January 17, 2022
New-Onset Ulcerative Colitis in a Young Caucasian Woman with Unclassified Arteritis
Bryan Roberts
Organic Letters
|
February 13, 2010
Novel aryl and heteroaryl acyl sulfamide synthesis via microwave-assisted palladium-catalyzed carbonylation
Bryan Roberts, David Liptrot, Lilian Alcaraz
Journal of Osteopathic Medicine
|
February 10, 2021
Effect of occipitoatlantal decompression on cerebral blood flow dynamics as evaluated by Doppler ultrasonography
Bryan Roberts, Andrew E Makar, Ryan Canaan, et al.
Organic Letters
|
August 28, 2010
Molybdenum-mediated carbonylation of aryl halides with nucleophiles using microwave irradiation
Bryan Roberts, David Liptrot, Lilian Alcaraz, et al.
The Journal of Vascular Access
|
October 8, 2025
Central venous access devices: Retrospective study of the implementation of a nursing led vascular access team and evaluation of complication rates
Shori Gerardot, Matthew Pope-Filos, Bronte Yono, et al.
The Journal of Organic Chemistry
|
April 21, 2015
Multidirectional Synthesis of Substituted Indazoles via Iridium-Catalyzed C-H Borylation
Scott A Sadler, Andrew C Hones, Bryan Roberts, et al.
Vaccine
|
December 5, 2006
Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens
George Mutwiri, Ponn Benjamin, Henry Soita, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2011
Lead optimisation of pyrazoles as novel FPR1 antagonists
Andrew D Morley, Sarah King, Bryan Roberts, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 23, 2003
Hit-to-lead studies: the discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists
Andrew Baxter, Colin Bennion, Janice Bent, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2011
Discovery of pyrazoles as novel FPR1 antagonists
Andrew D Morley, Andrew Cook, Sarah King, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Case Reports in Vascular Medicine
|
January 17, 2022
New-Onset Ulcerative Colitis in a Young Caucasian Woman with Unclassified Arteritis
Bryan Roberts
Organic Letters
|
February 13, 2010
Novel aryl and heteroaryl acyl sulfamide synthesis via microwave-assisted palladium-catalyzed carbonylation
Bryan Roberts, David Liptrot, Lilian Alcaraz
Journal of Osteopathic Medicine
|
February 10, 2021
Effect of occipitoatlantal decompression on cerebral blood flow dynamics as evaluated by Doppler ultrasonography
Bryan Roberts, Andrew E Makar, Ryan Canaan, et al.
Organic Letters
|
August 28, 2010
Molybdenum-mediated carbonylation of aryl halides with nucleophiles using microwave irradiation
Bryan Roberts, David Liptrot, Lilian Alcaraz, et al.
The Journal of Vascular Access
|
October 8, 2025
Central venous access devices: Retrospective study of the implementation of a nursing led vascular access team and evaluation of complication rates
Shori Gerardot, Matthew Pope-Filos, Bronte Yono, et al.
The Journal of Organic Chemistry
|
April 21, 2015
Multidirectional Synthesis of Substituted Indazoles via Iridium-Catalyzed C-H Borylation
Scott A Sadler, Andrew C Hones, Bryan Roberts, et al.
Vaccine
|
December 5, 2006
Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens
George Mutwiri, Ponn Benjamin, Henry Soita, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2011
Lead optimisation of pyrazoles as novel FPR1 antagonists
Andrew D Morley, Sarah King, Bryan Roberts, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 23, 2003
Hit-to-lead studies: the discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists
Andrew Baxter, Colin Bennion, Janice Bent, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2011
Discovery of pyrazoles as novel FPR1 antagonists
Andrew D Morley, Andrew Cook, Sarah King, et al.
Page
of 2